Accelerated brachytherapy and chemo for advanced cervical cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests a new way of delivering radiation therapy (brachytherapy) combined with chemotherapy for advanced cervical cancer. The goal is to see if a faster, more intense radiation schedule is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are newly diagnosed with cervical cancer at a specific stage (IB3 to IVA).
- Your cancer type is one of the common types: squamous cell, adenocarcinoma, or adenosquamous.
- You have not had radiation to the pelvic area before.
- You have no other cancers that could interfere with the trial.
- You have not had a hysterectomy (removal of the uterus) or do not plan to have one as part of your initial treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a shorter course of radiation therapy for advanced cervical cancer in women who cannot receive chemotherapy. The goal is to control the cancer and relieve symptoms with fewer treatment sessions, improving comfort and quality of life.
This trial tests a new immunotherapy drug, cadonilimab, combined with standard chemotherapy followed by chemoradiation for locally advanced cervical cancer. The goal is to see if this combination works better than current treatments.
This trial tests a new drug (QL1706) combined with chemotherapy before the usual radiation therapy for locally advanced cervical cancer. The goal is to see if this approach can shrink the tumor and improve outcomes.
This trial tests whether an “adaptive” type of radiation planning using proton therapy and MRI-guided brachytherapy can improve treatment for people with cervical cancer. It aims to deliver curative treatment more precisely while still combining it with chemotherapy (cisplatin) when appropriate.
This trial tests a faster, high-dose radiation treatment for cervical cancer that is given directly into the uterus. It aims to see if this approach is safe and effective for women with certain stages of the disease.
This trial is testing a combination of standard chemotherapy and radiation delivered to the pelvis, followed by an internal radiation treatment guided by CT scans. The goal is to improve treatment for locally advanced cervical cancer while potentially reducing side effects.
Hear when a new Locally Advanced Cervical Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.